| 1.26 Data as of Jun 18 |  -0.03 / -2.33%Today’s Change | 1.01 Today|||52-Week Range 2.94 | +2.44% Year-to-Date |
| Previous close | 1.29 |
| Today’s open | 1.28 |
| Day’s range | -- - -- |
| Volume | 369,673 |
| Average volume (3 months) | 192,842 |
| Market cap | $31.5M |
| Dividend yield | -- |
| Earnings growth (last year) | +59.29% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +19.00% |
| Revenue growth (last year) | +428.71% |
| P/E ratio | NM |
| Price/Sales | 11.63 |
| Price/Book | 1.12 |
| Today’s change | Today’s % change | |
|---|---|---|
| VRNMVerenium Corp | 0.00 | 0.00% |
| ROSGRosetta Genomics Ltd | -0.05 | -1.29% |
| GOGCGlobal Green Inc | -0.00 | -8.33% |
| GENEGenetic Technologies... | -0.11 | -4.12% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $2.3M |
| Annual profit (last year) | -$27.7M |
| Net profit margin | -1,204.73% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Vice Chairman, President & Chief Executive Officer Stephen M. Simes, MBA |
Vice President- Operations William D. Milling, CPA |
Corporate headquarters Lincolnshire, Illinois |
.
